Skip to main content

Blueprint Medicines Corp

BPMCDelisted Jul 18, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001597264

Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q2 2026

Institutional positions in Blueprint Medicines Corp as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

BPMC is no longer listed, and 13F filings after Q2 2025 list far fewer holders. See Q2 2025

Institutional holders
4
−2 vs. Q1 2026
Shares held
282
−44 (−13.5%) vs. Q1 2026
Total value
$129
−$38.5K (−99.7%) vs. Q1 2026
New holders
1
0 more added
Sold out
3
0 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BPMC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 4 institutions
Q1 2021: 264 institutionsQ2 2021: 281 institutionsQ3 2021: 289 institutionsQ4 2021: 280 institutionsQ1 2022: 248 institutionsQ2 2022: 237 institutionsQ3 2022: 240 institutionsQ4 2022: 223 institutionsQ1 2023: 215 institutionsQ2 2023: 222 institutionsQ3 2023: 220 institutionsQ4 2023: 260 institutionsQ1 2024: 282 institutionsQ2 2024: 305 institutionsQ3 2024: 319 institutionsQ4 2024: 346 institutionsQ1 2025: 353 institutionsQ2 2025: 356 institutionsQ3 2025: 12 institutionsQ4 2025: 8 institutionsQ1 2026: 6 institutionsQ2 2026: 4 institutions
Value heldQ2 2026: $129
Q1 2021: $5.69BQ2 2021: $5.14BQ3 2021: $6.13BQ4 2021: $6.32BQ1 2022: $3.82BQ2 2022: $3.19BQ3 2022: $4.15BQ4 2022: $2.74BQ1 2023: $2.84BQ2 2023: $4.03BQ3 2023: $3.25BQ4 2023: $5.91BQ1 2024: $6.25BQ2 2024: $7.15BQ3 2024: $6.04BQ4 2024: $5.86BQ1 2025: $6.12BQ2 2025: $8.65BQ3 2025: $2.58MQ4 2025: $2.57MQ1 2026: $38.6KQ2 2026: $129
Institutions holding BPMC and their total value by quarter
QuarterHoldersValue
Q2 20264$129
Q1 20266$38.6K
Q4 20258$2.57M
Q3 202512$2.58M
Q2 2025356$8.65B
Q1 2025353$6.12B
Q4 2024346$5.86B
Q3 2024319$6.04B
Q2 2024305$7.15B
Q1 2024282$6.25B
Q4 2023260$5.91B
Q3 2023220$3.25B
Q2 2023222$4.03B
Q1 2023215$2.84B
Q4 2022223$2.74B
Q3 2022240$4.15B
Q2 2022237$3.19B
Q1 2022248$3.82B
Q4 2021280$6.32B
Q3 2021289$6.13B
Q2 2021281$5.14B
Q1 2021264$5.69B

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Blueprint Medicines Corp; share changes are against Q1 2026.

Institutions holding BPMC in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Huntington National Bank1$1290.00%00.0%Unchanged
Massmutual Trust Co FSB9$00.00%00.0%Unchanged
Private Trust Co NA1$00.00%00.0%Unchanged
GAMMA Investing LLC271$00.00%+271New
Wall Street Access Asset Management, LLC0$00.00%−300−100.0%Sold out
Golden State Equity Partners0$00.00%−11−100.0%Sold out
Keating Financial Advisory Services, Inc.0$00.00%−4−100.0%Sold out